Startups
Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets. We offer pooled lentiviral shRNA and CRISPR libraries, pooled library screening and analysis by NGS, targeted RNA-Seq for biomarker discovery, lentiviral reagents, and stable cDNA, shRNA, and CRISPR constructs and isogenic cell lines.
Overview
Location
United States, California, Mountain View
Employees
11-50
Phone
(650) 938-3910
Total raised
$1.85M
Founded date
2006
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 6, 2022 | Flexible & Scalable Genetic Screens for Novel Therapeutic Target Discovery: An Overview of Noteworthy Case Studies, Upcoming Webinar Hosted by Xtalks | Cell-to-cell gene disruption induced by Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) technology and other gene-perturbation technologies help tease out the drivers of these responses. TORONTO (PRWEB) January 06, 2022 Me... |
| Oct 12, 2021 | Spatial Transcriptomics: Uses and Limitations of a Powerful Technique, Upcoming Webinar Hosted by Xtalks | The team at Cellecta uses the Nanostring GeoMx Digital Spatial Profiling (DSP) platform to provide simultaneous, highly multiplex spatial profiling of proteins or RNA in formalin-fixed paraffin-embedded (FFPE) tissues. TORONTO (PRWEB) Octob... |
| Aug 30, 2021 | Immunophenotyping of T-cell Receptor and B-cell Receptor Clonotypes, Upcoming Webinar Hosted by Xtalks | Register for this webinar to see data showing how combined TCR/BCR clonotype analysis combined with targeted expression profiling of immune cells can be applied for large-scale discovery of novel cell typing and activation biomarkers in sev... |
Reviews 0
FAQ about Cellecta, Inc.
When was Cellecta, Inc. founded?
Cellecta, Inc. was founded in 2006.
How much funding has Cellecta, Inc. raised?
Cellecta, Inc. has raised $1.85M in total across 1 funding round.
What has the press written about Cellecta, Inc.?
Parsers VC has collected 4 articles mentioning Cellecta, Inc., among them “Flexible & Scalable Genetic Screens for Novel Therapeutic Target Discovery: An Overview of Noteworthy Case Studies, Upcoming Webinar Hosted by Xtalks” (Jan 6, 2022) and “Spatial Transcriptomics: Uses and Limitations of a Powerful Technique, Upcoming Webinar Hosted by Xtalks” (Oct 12, 2021).
Is Cellecta, Inc. still active?
Yes, Cellecta, Inc. is active; its latest activity on Parsers VC dates from Apr 4, 2022.